

Mahuang, herbal ecstasy
Herbal Ectasy, Herbal fen-phen
Derived from the dried rhizome and root of the plant, ephedra has been used as a medicinal herb for thousands of years in India and China. It is commonly consumed in low doses and in combination with other herbs to promote urination and to treat asthma, bronchitis and coughs.
Ephedrine and pseudoephedrine, the major constituents, are non-selective sympathomimetic agents with both alpha and beta activities and have direct and indirect CNS stimulation effects, which account for the medicinal properties of the herb. Ephedra also has antibacterial and anti-inflammatory properties (1) (2) (3). Ephedra has been widely promoted as a natural stimulant and appetite suppressant. Although limited clinical data support this use, several cases of stroke, myocardial infarction and death in patients with no prior history of vascular disease have been reported (10).
Misuse and overdose of ephedra have resulted in heart attack, stroke, seizure, psychosis and death (8). Drug/herb interactions are major concerns (1) (4) (11) (14). Even a single dose of a weight loss supplement containing ephedra and caffeine increased QTc interval and systolic blood pressure significantly (15). The FDA has banned the sales of dietary supplements that contain ephedra because of their significant risk to human health (12) (13).
The major alkaloids in ephedra, ephedrine and pseudoephedrine, are CNS stimulants. They are non-selective sympathomimetic agents with both alpha and beta activities. These alkaloids can be used as decongestants because they constrict peripheral blood vessels, but in high doses, they also raise blood pressure (1) (2) (3). The CNS stimulation property contributes to ephedra’s appetite suppressant effects and its reputation as a weight loss agent (7). This effect, however, may lead to other cardiovascular adverse reactions such as stroke and heart attack (8). Ephedra’s antiasthmatic effect arises from its ability to relax bronchial smooth muscle. Studies indicate that ephedra also has antibacterial, antiinflammatory and uterine stimulatory activities (9).
The FDA has banned the sales of ephedra-containing dietary supplements. Consumers are urged not to buy or use these products (12) (13). These products have made unsubstantiated claims and may pose significant health risks (6). Possible adverse effects include hypertension, palpitations, heart attack, stroke, seizures, psychosis and death (10).
Aspirin: May increase risk of cerebral hemorrhage.
Benzodiazepines and other sedatives: Effects may be antagonized by ephedra.
Beta-adrenergic agonists: Ephedra may potentiate effects of beta-adrenergic agonists.
CNS stimulants: May increase stimulatory effects.
(1)
Theophylline: May decrease its effectiveness (18).
Digoxin: Concomitant use can cause arrhythmia (1) (11).
Monoamine-oxidase inhibitors (MAO-I): Concomitant use can cause hypertensive crisis (4).
Consumption of ephedra alkaloids may interfere with urine amphetamine test resulting in false-positive readings.
Ephedra may increase blood glucose levels.
(11)
Boozer C, et al. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord 2001;25:316-24.
Sixty-seven subjects participated in a randomized, double-blind placebo controlled study. They were given supplements containing 72 mg of ephedra and 240 mg of caffeine per day. After eight weeks, subjects from the active treatment group lost an average of 4.0 kg as compared to 0.4 kg in the placebo group. Serum triglyceride and hip circumference were also reduced in the active treatment group. The study concluded that this mixture effectively promoted short-term weight and fat loss. However, adverse symptoms such as dry mouth, insomnia and headache were reported. More studies are needed to explore the long-term effects.
Samenuk D, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77:12-6.
Based on the data obtained from the comprehensive database Adverse Reaction Monitoring System of FDA, the authors found 926 cases of possible ephedra toxicity reported between 1995 and 1997. Analysis of 37 cases indicated that ephedra and related products can cause stroke, myocardial infarction and sudden death. These adverse effects are not dose-related and can happen to patients with no prior history of vascular disease.
Bottom Line: Ephedra is a stimulant that has caused several deaths from heart attack and stroke.
Ephedra contains ephedrine and pseudoephedrine, which are known to stimulate the central nervous system (brain and spinal cord). They activate the “fight or flight” response, resulting in constriction of blood vessels, relaxation and dilation of air passages, appetite suppression, and general stimulant effects. While these effects explain the use of ephedra as a decongestant, weight loss supplement, and anti-asthma agent, in high doses ephedra can raise blood pressure and cause adverse reactions such as stroke and heart attack. Even a single dose of an ephedra containing supplement can cause dangerous increases in blood pressure and effects on heart function. Laboratory studies indicate that ephedra also can kill bacteria on contact, reduce inflammation, and cause contraction of the muscles of the uterus. These effects have not been studied in humans.
Weight loss:
The effect of a supplement containing ephedra and caffeine on weight loss was examined in a randomized controlled trial with 67 overweight subjects. They were given either the active supplement (containing 72 mg of ephedra and 240 mg of caffeine) or a placebo pill every day for eight weeks. At the end of the study, subjects taking the active supplement lost an average of 8.8 lb as compared to 0.88 lb in the placebo group. Blood triglyceride levels and hip circumference were also reduced in the active treatment group. Several adverse symptoms such as dry mouth, insomnia and headache were reported. It is unclear from this study if the effects were more from ephedra or guarana, or what the long-term health effects are.
Toxicities associated with ephedra:
A group of researchers conducted a review of the F.D.A. Adverse Reaction Monitoring System database to compile a list of toxicities associated with ephedra. They found 926 cases of possible ephedra toxicity between 1995 and 1997. Closer analysis of 37 cases indicated that ephedra and related products can cause stroke, heart attack, and sudden death. These adverse effects are not related to the dose taken and can happen to patients with no prior history of heart disease.